Inventor · disambiguated record
Matthias Klugmann
Also filed as: KLUGMANN MATTHIAS
1 granted patent·5 pending applications·2 citations·filing 2013–2021
18Inventor score
Files withNEWSOUTH INNOVATIONS PTY LTD3BOEHRINGER INGELHEIM INT1SHIRE HUMAN GENETIC THERAPIES1TAKEDA PHARMACEUTICALS CO1
Top patents by PatentIndex Score
6 records- 0152US2024076689A1Viral vectors and nucleic acids for regulated gene therapyBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0251US2017202932A1Methods for inhibiting neuron apoptosis and necrosisNEWSOUTH INNOVATIONS PTY LTD·Filed 2017·Application pending·0 cites
- 0350US11013917B2Method and apparatus for close-field electroporationNEWSOUTH INNOVATIONS PTY LTD·Filed 2014·Granted May 25, 2021·2 cites·20 claims
- 0448US2023043051A1Adeno-associated virus vectors based gene therapy for hereditary angioedemaSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 0548US2023055020A1Adeno associated virus based gene therapy for phenylketonuriaTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 0646US2015190366A1Methods for inhibiting neuron apoptosis and necrosisNEWSOUTH INNOVATIONS PTY LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Klugmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →